Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by GC Wealth Management RIA LLC

GC Wealth Management RIA LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,089 shares of the medical equipment provider’s stock after selling 170 shares during the period. GC Wealth Management RIA LLC’s holdings in Intuitive Surgical were worth $1,090,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in ISRG. Massachusetts Financial Services Co. MA acquired a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $558,807,000. Proficio Capital Partners LLC boosted its position in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after buying an additional 948,902 shares during the period. FMR LLC boosted its position in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $313,769,000. Finally, Wilmington Savings Fund Society FSB increased its stake in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on ISRG shares. Barclays upped their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Finally, Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $482.61 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a fifty day moving average price of $570.48 and a two-hundred day moving average price of $531.79. The company has a market cap of $171.90 billion, a PE ratio of 75.29, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Insider Activity

In other news, EVP Myriam Curet sold 408 shares of the stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,309 shares of company stock worth $7,611,004. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.